The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections

Esther E. Freeman*, Cristina Galvan Casas, Sonya Prasad, Claire Fuller, Klint Peebles, Misha Rosenbach, Lindy Fox, Devon E. McMahon, Alexis Strahan, Janet Lubov, Geoffrey Chen, Cuong V. Nguyen, Allen McMillen, Henry W. Lim, Alexander J. Stratigos, Mark D. Kaufmann, George J. Hruza, Lars French

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

The World Health Organization declared the global monkeypox outbreak a public health emergency of international concern in July 2022. In response, the American Academy of Dermatology and International League of Dermatological Societies expanded the existing COVID-19 Dermatology Registry to become the “AAD/ILDS Dermatology COVID-19, Monkeypox, and Emerging Infections Registry.” The goal of the registry is to rapidly collate cases of monkeypox and other emerging infections and enable prompt dissemination of findings to front-line healthcare workers and other members of the medical community. The registry is now accepting reports of monkeypox cases and cutaneous reactions to monkeypox/smallpox vaccines. The success of this collaborative effort will depend on active case entry by the global dermatology community.

Original languageEnglish (US)
Pages (from-to)1278-1280
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume87
Issue number6
DOIs
StatePublished - Dec 2022

Keywords

  • clinical research
  • general dermatology
  • infectious disease
  • medical dermatology
  • monkeypox
  • vaccine
  • virus

ASJC Scopus subject areas

  • Dermatology

Fingerprint

Dive into the research topics of 'The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections'. Together they form a unique fingerprint.

Cite this